cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Inmune Bio Inc
2 own
1 watching
Current Price
$8.37
$-0.43
(-4.89%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
129.39M
52-Week High
52-Week High
14.74000
52-Week Low
52-Week Low
6.50000
Average Volume
Average Volume
0.07M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization129.39M
icon52-Week High14.74000
icon52-Week Low6.50000
iconAverage Volume0.07M
iconDividend Yield--
iconP/E Ratio--
What does the Inmune Bio Inc do?
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient s innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma and patients with high-risk myelodysplastic syndrome; INB03, an immunotherapy that treats patients with hematologic malignancies and solid tumors; and XPro1595 for the treatment of Alzheimer's disease. The company has license agreements with Xencor, Inc.; Immune Ventures, LLC; University of Pittsburg; and University College London. INmune Bio, Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida.
Read More
How much money does Inmune Bio Inc make?
News & Events about Inmune Bio Inc.
Globe Newswire
12 months ago
Management to host conference call and webcast at 4:30 pm ET on that day Boca Raton, Florida, April 24, 2023 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the Company), a clinical-stage immunology company focused ondeveloping treatments that harness a patients innate immune system to fight ...
Globe Newswire
1 year ago
BOCA RATON, Fla., April 03, 2023 (GLOBE NEWSWIRE) -- INmune Bio, Inc.(NASDAQ: INMB)(the Company), a clinical-stage immunology company focused on developing treatments that harness the patients innate immune system to fight disease, today announced that the Company has submitted an Investigational ...
Ticker Report
1 year ago
INmune Bio, Inc. (NASDAQ:INMB Get Rating) CFO David J. Moss acquired 2,500 shares of the businesss stock in a transaction dated Friday, March 17th. The shares were bought at an average price of $6.42 per share, with a total value of $16,050.00. Following the transaction, the chief ...
Globe Newswire
1 year ago
Management to host conference call and webcast at 4:30 pm ET on that day Boca Raton, Florida, Feb. 21, 2023 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the Company), a clinical-stage immunology company focused ondeveloping treatments that harness a patients innate immune system to fight ...
Globe Newswire
1 year ago
BOCA RATON, Fla., Feb. 08, 2023 (GLOBE NEWSWIRE) -- INmune Bio, Inc.(NASDAQ: INMB) (the Company), a clinical-stage immunology company focused on developing treatments that harness the patients innate immune system to fight disease, today announces that it has received a combined approximately $6.4 ...
Frequently Asked Questions
Frequently Asked Questions
What is Inmune Bio Inc share price today?
plus_minus_icon
Can Indians buy Inmune Bio Inc shares?
plus_minus_icon
How can I buy Inmune Bio Inc shares from India?
plus_minus_icon
Can Fractional shares of Inmune Bio Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Inmune Bio Inc stocks?
plus_minus_icon
What is today’s traded volume of Inmune Bio Inc?
plus_minus_icon
What is today’s market capitalisation of Inmune Bio Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Inmune Bio Inc?
plus_minus_icon
What percentage is Inmune Bio Inc down from its 52-Week High?
plus_minus_icon
What percentage is Inmune Bio Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$8.37
$-0.43
(-4.89%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00